Reducing overtreatment associated with overdiagnosis in cervical cancer screening—A model‐based benefit–harm analysis for Austria-Reference-Cited by-同舟云学术

Reducing overtreatment associated with overdiagnosis in cervical cancer screening—A model‐based benefit–harm analysis for Austria

Published:2020-01-13 Issue:4 Volume:147 Page:1131-1142
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Sroczynski Gaby¹²^ORCID,Esteban Eva¹²,Widschwendter Andreas³,Oberaigner Wilhelm⁴,Borena Wegene⁵^ORCID,Laer Dorothee⁵^ORCID,Hackl Monika⁶,Endel Gottfried⁷,Siebert Uwe¹²⁸⁹^ORCID

Affiliation:

1. Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology AssessmentUMIT ‐ University for Health Sciences, Medical Informatics and Technology Hall i.T. Austria

2. Division of Health Technology Assessment and BioinformaticsONCOTYROL ‐ Center for Personalized Cancer Medicine Innsbruck Austria

3. Department of Obstetrics and GynecologyMedical University Innsbruck Innsbruck Austria

4. Institute for Clinical EpidemiologyCancer Registry Tyrol, Tirol Kliniken Innsbruck Austria

5. Division of Virology, Department of Hygiene, Microbiology, Social MedicineMedical University of Innsbruck Innsbruck Austria

6. Statistics AustriaAustrian National Cancer Registry Vienna Austria

7. Department for Evidence‐Based Economic Health CareMain Association of Austrian Social Insurance Institutions Vienna Austria

8. Center for Health Decision Science, Department of Health Policy and ManagementHarvard T.H. Chan School of Public Health Boston MA

9. Institute for Technology Assessment and Department of RadiologyMassachusetts General Hospital, Harvard Medical School Boston MA

Funder

Österreichische Forschungsförderungsgesellschaft

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32849

Reference50 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document

3. Statistik Austria. Gebärmutterhals (C53). Available at:http://www.statistik.at/web_de/statistiken/menschen_und_gesellschaft/gesundheit/krebserkrankungen/gebaermutterhals/index.html.

4. Leitlinie für die Diagnose und Therapie von Cervikalen Intraepithelialen Neoplasien (CIN) und Mikrokarzinomen der Cervix uteri;Breitenecker G;Speculum,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Cervical Cancer Prevention in South African Women: Primary HPV mRNA Screening with Different Genotype Combinations;Cancers;2023-11-17

2. Data-driven overdiagnosis definitions: A scoping review;Journal of Biomedical Informatics;2023-11

3. Long‐term benefits and harms of early colorectal cancer screening in German individuals with familial cancer risk;International Journal of Cancer;2023-10-05

4. HPV-associated cervical cancer: Current status and prospects;Acta Biomedica Scientifica;2023-07-11

5. Decision-analytic evaluation of the comparative effectiveness and cost-effectiveness of strategies to prevent breast and ovarian cancer in German women with BRCA-1/2 mutations;BMC Cancer;2023-06-26